View in EDS HTML Full Text PDF Full Text

Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.

Saved in:
Bibliographic Details
Title: Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.
Authors: Aguilera-Diaz A; Advanced Genomics Laboratory, Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Vazquez I; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Ariceta B; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Mañú A; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Blasco-Iturri Z; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Palomino-Echeverría S; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Larrayoz MJ; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., García-Sanz R; Hematology Department, University Hospital of Salamanca, IBSAL and CIBERONC, Salamanca, Spain., Prieto-Conde MI; Hematology Department, University Hospital of Salamanca, IBSAL and CIBERONC, Salamanca, Spain., Del Carmen Chillón M; Hematology Department, University Hospital of Salamanca, IBSAL and CIBERONC, Salamanca, Spain., Alfonso-Pierola A; Hematology Department, Clinica Universidad de Navarra (CUN), Pamplona, Spain., Prosper F; Advanced Genomics Laboratory, Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Hematology Department, Clinica Universidad de Navarra (CUN), Pamplona, Spain., Fernandez-Mercado M; Advanced Genomics Laboratory, Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; Biomedical Engineering Department, School of Engineering, University of Navarra, San Sebastian, Spain., Calasanz MJ; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; Scientific Co-Director of CIMA LAB Diagnostics, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.
Source: PloS one [PLoS One] 2020 Jan 24; Vol. 15 (1), pp. e0227986. Date of Electronic Publication: 2020 Jan 24 (Print Publication: 2020).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31978184
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Aguilera-Diaz+A%22">Aguilera-Diaz A</searchLink>; Advanced Genomics Laboratory, Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Vazquez+I%22">Vazquez I</searchLink>; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Ariceta+B%22">Ariceta B</searchLink>; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Mañú+A%22">Mañú A</searchLink>; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Blasco-Iturri+Z%22">Blasco-Iturri Z</searchLink>; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Palomino-Echeverría+S%22">Palomino-Echeverría S</searchLink>; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Larrayoz+MJ%22">Larrayoz MJ</searchLink>; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22García-Sanz+R%22">García-Sanz R</searchLink>; Hematology Department, University Hospital of Salamanca, IBSAL and CIBERONC, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Prieto-Conde+MI%22">Prieto-Conde MI</searchLink>; Hematology Department, University Hospital of Salamanca, IBSAL and CIBERONC, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Del+Carmen+Chillón+M%22">Del Carmen Chillón M</searchLink>; Hematology Department, University Hospital of Salamanca, IBSAL and CIBERONC, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Alfonso-Pierola+A%22">Alfonso-Pierola A</searchLink>; Hematology Department, Clinica Universidad de Navarra (CUN), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Prosper+F%22">Prosper F</searchLink>; Advanced Genomics Laboratory, Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Hematology Department, Clinica Universidad de Navarra (CUN), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Fernandez-Mercado+M%22">Fernandez-Mercado M</searchLink>; Advanced Genomics Laboratory, Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; Biomedical Engineering Department, School of Engineering, University of Navarra, San Sebastian, Spain.<br /><searchLink fieldCode="AU" term="%22Calasanz+MJ%22">Calasanz MJ</searchLink>; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; Scientific Co-Director of CIMA LAB Diagnostics, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2020 Jan 24; Vol. 15 (1), pp. e0227986. <i>Date of Electronic Publication: </i>2020 Jan 24 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31978184
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0227986
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e0227986
    Titles:
      – TitleFull: Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Aguilera-Diaz A
      – PersonEntity:
          Name:
            NameFull: Vazquez I
      – PersonEntity:
          Name:
            NameFull: Ariceta B
      – PersonEntity:
          Name:
            NameFull: Mañú A
      – PersonEntity:
          Name:
            NameFull: Blasco-Iturri Z
      – PersonEntity:
          Name:
            NameFull: Palomino-Echeverría S
      – PersonEntity:
          Name:
            NameFull: Larrayoz MJ
      – PersonEntity:
          Name:
            NameFull: García-Sanz R
      – PersonEntity:
          Name:
            NameFull: Prieto-Conde MI
      – PersonEntity:
          Name:
            NameFull: Del Carmen Chillón M
      – PersonEntity:
          Name:
            NameFull: Alfonso-Pierola A
      – PersonEntity:
          Name:
            NameFull: Prosper F
      – PersonEntity:
          Name:
            NameFull: Fernandez-Mercado M
      – PersonEntity:
          Name:
            NameFull: Calasanz MJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 01
              Text: 2020 Jan 24
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1932-6203
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: PloS one
              Type: main
ResultId 1